comparemela.com
Home
Live Updates
Medicus Pharma Ltd. Publishes Phase 1 Clinical Study Report Demonstrating Safety & Tolerability in All Participants with Basal Cell Carcinoma : comparemela.com
Medicus Pharma Ltd. Publishes Phase 1 Clinical Study Report Demonstrating Safety & Tolerability in All Participants with Basal Cell Carcinoma
Medicus Pharma Ltd. is pleased to announce that it has published the abbreviated clinical study report from the SKNJCT-001 Phase 1 safety and tolerability study. SKNJCT-001 is an open-label,...
Related Keywords
Toronto ,
Ontario ,
Canada ,
United States ,
Tirtht Patel ,
Carolyn Bonner ,
Drug Administration ,
Wealth Securities Limited ,
Skinject Inc ,
Medicus Pharma Ltd ,
Trading Group ,
Newsfile Corp ,
United States Food ,
New Drug ,
Independent Trading Group ,
Integral Wealth Securities Limited ,
Markets ,
comparemela.com © 2020. All Rights Reserved.